EFTA02251729

To: From: Fernandez, Kristen Sent: Wed 7/18/2018 3:20:02 PM Subject: RE: Jeffrey Epstein Hi I will begin scheduling surgeries more aggressively starting in August. And we have a strict 3 week cancellation policy when it comes to surgeries. We can discuss in about 2 weeks if that's better for you. Kindest regards, 'Patients: going forward, please utilize MyChart for secure messaging, prescription refills, appointment verification, and to view and/or pay bills. Please go to mychart.nyulmc.org to sign up. If you need help recovering a assword or have other technical issues, please contact the MyChart help desk at Kristen Fernandez FGP Cosmetic Operations Lead Clinical Administrative Assistant 5 Surgical Coordinator to Eduardo D. Rodriguez, MD, DDS Chair, The Hansjorg Wyss Department of Plastic Surgery Helen L. Kimmel Professor of Reconstructive Plastic Surgery NYU Faculty Group Practice CONFIDENTIALITY NOTICE: This message is for the sole use of the intended recipient(s) and may contain confidential, proprietary, and/or protected health information. Under the Federal Law (HIPAA) or other confidentiality protections, the intended recipient is obligated to keep this information secure and confidential, and may only use or disclose it in a manner permitted under HIPAA or other protections. If you are not a designated recipient, you may not review, copy, or distribute this message. If you receive this in error, please notify the sender by reply e-mail and delete this message. Thank you. Please do not print this e-mail unless necessary. Ori inal Messa e From: Sent: We nes ay, Ju y , : AM To: Fernandez, Kristen Subject: Jeffrey Epstein Hello Kristen_I spoke with Jeffrey re when he would like to schedule the surgery...he says in September...as September approaches may we circle back to a date? How much lead time do you need to get on Dr. Rodriguez's calendar? Thanks Assistant to Jeffrey Epstein This email message, including any attachments, is for the sole use of the intended recipient(s) and may contain information that is proprietary, EFTA_R1_01039740 EFTA02251729 confidential, and exempt from disclosure under applicable law. Any unauthorized review, use, disclosure, or distribution is prohibited. If you have received this email in error please notify the sender by return email and delete the original message. Please note, the recipient should check this email and any attachments for the presence of viruses. The organization accepts no liability for any damage caused by any virus transmitted by this email. ======= EFTA_R1_01039741 EFTA02251730